abstract |
The invention relates to the use of heterocyclic compounds of formula Het-A-Ar, in which Het, A, B and Ar have the meanings given in the description. The compounds have high affinity for the dopamine D3 receptor and are therefore used to treat diseases that respond to dopamine D3 ligands. |